Genext Genomics Pvt Ltd

Genext Genomics is a research-driven biopharma company specializing in protein engineering and committed to addressing the critical gap in antibody manufacturing. The company's vision is to lead innovation in antibody development with a strong focus on therapeutic and diagnostic applications.GNG has developed Golimumab Biosimilar clone under the NBM, BIRAC with a current titer of 3G/L with all CQA and process developed matched with Innovator. Along with this GNG has 4 molecule in pipeline. With expertise in clone development and RCB generation till pre-clinical, GNG gives a platform to all the biopharma client to have end to end services both for Novel as well as Biosimilar. The company seeks strategic partnerships to further develop and commercialize its therapeutic molecules, leveraging its strong foundation in antibody engineering.With a robust pipeline and a commitment to innovation, GNG invites collaboration to transform groundbreaking discoveries into life-saving therapies.